Internal Medicine, Interventional Cardiology · Fremont, CA
NPI
1508849860
Since 2005
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
39231 Liberty St
Fremont, CA, 94538
Phone (510) 795-1700
Groups this clinician bills Medicare through
Medicare paid, 2024
$306K
4,858 services
Medicare patients, 2024
1,410
Average age 76
Drug cost, 2024
$1.2M
4,260 prescriptions
Company payments, 2025
$1,773
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Steven B Degalan was code 99213 (office e&m - established), 1,104 times for 452 patients. In total Steven B Degalan billed 4,858 services in 48 codes, and Medicare paid $306K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-05-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,104 | 452 | $78.27 | $86K |
| 93010 Electrocardiogram | Facility | 808 | 661 | $6.83 | $5,515 |
| 99232 Hospital E&M - Subsequent | Facility | 636 | 235 | $72.37 | $46K |
| 93000 Electrocardiogram | Office | 499 | 353 | $12.38 | $6,177 |
| 93306 Echocardiography (TTE/TEE) | Office | 223 | 223 | $191.64 | $43K |
| 93297 External Electrocardiographic Monitoring | Office | 220 | 22 | $58.42 | $13K |
| 93306 Echocardiography (TTE/TEE) | Facility | 191 | 186 | $61.74 | $12K |
| 99223 Hospital E&M - Initial | Facility | 167 | 139 | $157.59 | $26K |
| 82962 Clinical Chemistry | Office | 155 | 50 | $3.21 | $498 |
| 99231 Hospital E&M - Subsequent | Facility | 126 | 33 | $44.91 | $5,659 |
| 99204 Office E&M - New | Office | 78 | 78 | $129.81 | $10K |
| 99214 Office E&M - Established | Office | 70 | 56 | $117.87 | $8,251 |
| 93296 External Electrocardiographic Monitoring | Office | 67 | 24 | $23.39 | $1,567 |
| 93294 External Electrocardiographic Monitoring | Office | 52 | 17 | $23.69 | $1,232 |
| 93246 Electrocardiogram | Office | 44 | 43 | $13.12 | $577 |
By year: 2022 $303K for 5,075 services; 2023 $322K for 5,001 services; 2024 $306K for 4,858 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 155 | 50 | $3.21 | $498 |
Medicare prescription drug claims, 2024
In 2024, the drug Steven B Degalan prescribed most often to Medicare patients was Eliquis (Apixaban), with 247 prescriptions and refills. In total Steven B Degalan wrote 4,260 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 247 | 477 | 61 | $276K |
| Amlodipine Besylate Generic | 236 | 640 | 75 | $949 |
| Rosuvastatin Calcium Generic | 228 | 593 | 62 | $4,266 |
| Atorvastatin Calcium Generic | 189 | 533 | 56 | $1,712 |
| Metoprolol Succinate Generic | 179 | 491 | 61 | $2,558 |
| Carvedilol Generic | 176 | 363 | 44 | $1,050 |
| Clopidogrel Clopidogrel Bisulfate | 168 | 454 | 51 | $1,910 |
| Olmesartan Medoxomil Generic | 151 | 448 | 50 | $2,754 |
| Losartan Potassium Generic | 103 | 265 | 29 | $974 |
| Jardiance Empagliflozin | 95 | 143 | 22 | $79K |
| Entresto Sacubitril/Valsartan | 81 | 111 | 16 | $70K |
| Torsemide Generic | 70 | 158 | 23 | $957 |
| Lisinopril Generic | 70 | 164 | 17 | $461 |
| Propafenone Hcl Generic | 67 | 133 | 22 | $2,704 |
| Pioglitazone Hcl Generic | 62 | 178 | 19 | $749 |
Brand drugs: - claims; generic drugs: 3,373 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Steven B Degalan $1,773 ($1,773 in general payments such as food, travel and fees) from 12 companies. The largest payer was Abbott Laboratories with $522.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 15 | $522 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $313 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 11 | $305 |
| Novo Nordisk Inc NVO | 9 | $144 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $121 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $101 |
| Actelion Pharmaceuticals US, Inc. JNJ | 3 | $70.02 |
| Boston Scientific Corporation BSX | 3 | $69.95 |
| Amgen Inc. AMGN | 2 | $45.92 |
| Heartflow, Inc. HTFL | 1 | $35.21 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.